The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zovirax 800 mg Dispersible Tablets

800 milligram(s) Dispersible tablet

LTT Pharma LimitedPPA1562/183/002

Main Information

Trade NameZovirax 800 mg Dispersible Tablets
Active SubstancesACICLOVIR
Strength800 milligram(s)
Dosage FormDispersible tablet
Licence HolderLTT Pharma Limited
Licence NumberPPA1562/183/002

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB01 aciclovir

Status

Authorised/WithdrawnAuthorised
Licence Issued11/11/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back